Arcutis Biotherapeutics Inc (ARQT)
9.43
+0.17
(+1.84%)
USD |
NASDAQ |
Nov 18, 16:00
9.53
+0.10
(+1.06%)
Pre-Market: 08:29
Arcutis Biotherapeutics Total Assets (Quarterly): 437.35M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 437.35M |
| June 30, 2024 | 444.76M |
| March 31, 2024 | 478.54M |
| December 31, 2023 | 341.36M |
| September 30, 2023 | 292.96M |
| June 30, 2023 | 320.69M |
| March 31, 2023 | 379.46M |
| December 31, 2022 | 449.27M |
| September 30, 2022 | 508.91M |
| June 30, 2022 | 300.46M |
| March 31, 2022 | 364.11M |
| Date | Value |
|---|---|
| December 31, 2021 | 408.15M |
| September 30, 2021 | 387.01M |
| June 30, 2021 | 432.89M |
| March 31, 2021 | 471.42M |
| December 31, 2020 | 298.27M |
| September 30, 2020 | 198.01M |
| June 30, 2020 | 231.97M |
| March 31, 2020 | 254.39M |
| December 31, 2019 | 107.01M |
| September 30, 2019 | 28.30M |
| December 31, 2018 | 51.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
107.01M
Minimum
Dec 2019
508.91M
Maximum
Sep 2022
355.35M
Average
371.78M
Median
Total Assets (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 667.89M |
| Biogen Inc | 28.31B |
| Vertex Pharmaceuticals Inc | 22.24B |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 280.71M |
| Shareholders Equity (Quarterly) | 156.64M |
| Debt to Equity Ratio | 1.306 |
| Current Ratio | 2.457 |
| Net Debt Paydown Yield | -0.09% |